Zhongxin Pharmaceutical

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited is a national high-tech enterprise controlled by Tianjin Pharmaceutical Group. With a focus on innovation in traditional Chinese medicine (TCM), the company integrates production, operations, and research. It primarily engages in the production, operation, and commercialization of TCM patent medicines, raw herbal materials, chemical drugs, nutritional health products, and pharmaceuticals, forming two core business segments: TCM manufacturing and pharmaceutical commerce. Currently, the company has 22 branches, 10 wholly-owned subsidiaries, 7 controlled subsidiaries, and 6 participating companies under its umbrella.